Inhibition of the TNF-Pathway: Use of Infliximab and Etanercept As Remission-Inducing Agents in Cases of Therapy-Resistant Chronic Inflammatory Disorders. Swiss Med Wkly 2002, 132 (2930), 414-414. https://doi.org/10.4414/smw.2002.10031.